|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
None
|
Not Applicable
|
Not Applicable
|
Large accelerated filer ☐
|
|
Non-accelerated filer ☐
|
Smaller reporting company |
Emerging growth company |
PART I. - FINANCIAL INFORMATION
|
Page
|
||
|
|
|
|
|
Item 1 - Financial Statements
|
|
|
|
|
3
|
|
|
|
4
|
|
|
|
5
|
|
|
|
6
|
|
|
|
7
|
|
|
|
8
|
|
|
|
|
|
|
28
|
||
|
|
|
|
|
50 | ||
|
|
|
|
|
Item 4 - Controls and Procedures
|
52
|
|
|
|
|
|
PART II. - OTHER INFORMATION
|
|
||
|
|
|
|
|
Item 1 – Legal Proceedings
|
53
|
|
|
Item 1A – Risk Factors
|
53
|
|
|
53
|
||
|
Item 3 – Defaults upon Senior Securities
|
54
|
|
|
Item 4 – Mine Safety Disclosures
|
54
|
|
|
Item 5 – Other Information
|
54
|
|
|
Item 6 – Exhibits
|
54
|
|
|
55
|
Item 1.
|
Financial Statements
|
(Dollars in thousands, except share and per share amounts)
|
September 30,
2023
|
December 31,
2022
|
||||||
ASSETS
|
||||||||
Cash and due from banks
|
$
|
|
$
|
|
||||
Interest bearing deposits with banks
|
|
|
||||||
Total cash and cash equivalents
|
|
|
||||||
Securities available-for-sale, amortized cost $
|
|
|
||||||
Securities held-to-maturity, fair
value $
|
|
|
||||||
Allowance for credit losses - securities held-to-maturity
|
( |
) | ( |
) | ||||
Total investment securities
|
|
|
||||||
Non-marketable securities
|
|
|
||||||
Loans and leases held-for-investment, net of unearned income
|
|
|
||||||
Allowance for credit losses - loans and leases
|
(
|
)
|
(
|
)
|
||||
Loans held-for-investment, net
|
|
|
||||||
Bank-owned life insurance
|
|
|
||||||
Premises and equipment, net
|
|
|
||||||
Deferred income tax assets
|
|
|
||||||
Accrued interest receivable
|
|
|
||||||
Goodwill
|
|
|
||||||
Other intangibles
|
|
|
||||||
Other real estate owned
|
|
|
||||||
Other assets
|
|
|
||||||
TOTAL ASSETS
|
$
|
|
$
|
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
Deposits:
|
||||||||
Non-interest bearing
|
$
|
|
$
|
|
||||
Interest bearing:
|
||||||||
Demand
|
|
|
||||||
Savings and money market
|
|
|
||||||
Certificates of deposit
|
|
|
||||||
Total interest bearing
|
|
|
||||||
Total deposits
|
|
|
||||||
Subordinated debentures
|
|
|
||||||
Interest payable and other liabilities
|
|
|
||||||
TOTAL LIABILITIES
|
|
|
||||||
SHAREHOLDERS’ EQUITY
|
||||||||
Preferred shares,
|
|
|
||||||
Common shares, $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Accumulated other comprehensive (loss), net of taxes
|
(
|
)
|
(
|
)
|
||||
TOTAL SHAREHOLDERS’ EQUITY
|
|
|
||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$
|
|
$
|
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||||||||||
(Dollars in thousands, except share and per share amounts) |
2023
|
2022
|
2023
|
2022
|
||||||||||||
Interest income
|
||||||||||||||||
Interest and fees on loans and leases
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Interest and dividends on investment securities
|
|
|
|
|
||||||||||||
Interest on deposits with others
|
||||||||||||||||
Total interest income
|
|
|
|
|
||||||||||||
Interest expense
|
||||||||||||||||
Deposits
|
|
|
|
|
||||||||||||
Subordinated debentures
|
|
|
|
|
||||||||||||
Total interest expense
|
|
|
|
|
||||||||||||
Net interest income
|
|
|
|
|
||||||||||||
Provision for credit losses
|
|
|
|
|
||||||||||||
Net interest income after provision for credit losses
|
|
|
|
|
||||||||||||
Non-interest income
|
||||||||||||||||
Card processing
|
||||||||||||||||
Service charges on deposit accounts
|
|
|
|
|
||||||||||||
Increase in cash surrender value of BOLI
|
|
|
|
|
||||||||||||
Gain on BOLI death benefit
|
||||||||||||||||
Net loss on sale of securities available-for-sale
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||
Net (loss)/gain on deferred compensation benefits
|
(
|
)
|
|
|
(
|
)
|
||||||||||
Other
|
|
|
|
|
||||||||||||
Total non-interest income
|
|
|
|
|
||||||||||||
Non-interest expense
|
||||||||||||||||
Salaries and employee benefits
|
|
|
|
|
||||||||||||
Net (loss)/gain on deferred compensation benefits
|
(
|
)
|
|
|
(
|
)
|
||||||||||
Data processing
|
|
|
|
|
||||||||||||
Occupancy
|
||||||||||||||||
FDIC insurance
|
||||||||||||||||
Marketing
|
|
|
|
|
||||||||||||
Legal
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total non-interest expense
|
|
|
|
|
||||||||||||
INCOME BEFORE INCOME TAXES
|
|
|
|
|
||||||||||||
Income tax expense
|
|
|
|
|
||||||||||||
NET INCOME
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Earnings per common share:
|
||||||||||||||||
Basic
|
$ | $ | $ | $ | ||||||||||||
Diluted
|
$ | $ | $ | $ | ||||||||||||
Weighted average number of common shares | ||||||||||||||||
Basic
|
||||||||||||||||
Diluted
|
|
Three Months Ended
September 30,
|
Nine Months Ended
September 30,
|
||||||||||||||
(Dollars in thousands) |
2023
|
2022
|
2023
|
2022
|
||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Other comprehensive income
|
||||||||||||||||
Unrealized (losses) on available-for-sale securities
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Reclassification adjustment for losses on available-for-sale securities
|
|
|
|
|
||||||||||||
Amortization of unrealized loss on securities transferred to held-to-maturity
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Net unrealized (losses)/gains on available-for-sale securities
|
( |
) | ( |
) | ( |
) | ||||||||||
Income tax benefit/(expense)
|
|
|
(
|
)
|
|
|||||||||||
Other comprehensive (loss)/income, net of tax
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||
Total comprehensive income
|
$
|
|
$
|
|
$
|
|
$
|
|
For the three and nine months ended September 30, 2023 and 2022 |
||||||||||||||||||||||||
(Dollars in thousands, except share amounts)
|
Common
Shares
|
Amount |
Additional
Paid-In
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
(Loss)/Income
|
Total
|
||||||||||||||||||
Balance as of June 30, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||
Net income
|
- |
|
|
|
|
|||||||||||||||||||
Other comprehensive loss, net of tax
|
- |
|
|
|
(
|
)
|
(
|
)
|
||||||||||||||||
Repurchase of common stock | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Balance as of September 30, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||
Balance as of June 30, 2022
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||
Net income
|
- |
|
|
|
|
|||||||||||||||||||
Other comprehensive loss, net of tax
|
- |
|
|
|
(
|
)
|
(
|
)
|
||||||||||||||||
Repurchase of common stock
|
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Balance as of September 30, 2022
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
(Dollars in thousands, except share amounts)
|
Common
Shares
|
Amount |
Additional
Paid-In
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
(Loss)/Income
|
Total
|
||||||||||||||||||
Balance as of December 31, 2022
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||
Net income
|
- |
|
|
|
|
|||||||||||||||||||
Other comprehensive gain, net of tax
|
- |
|
|
|
|
|
||||||||||||||||||
Cash dividends declared ($
|
- | ( |
) | ( |
) | |||||||||||||||||||
Repurchase of common stock | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Balance as of September 30, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||
Balance as of December 31, 2021
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||||||
Net income
|
- |
|
|
|
|
|||||||||||||||||||
Other comprehensive loss, net of tax
|
- |
|
|
|
(
|
)
|
(
|
)
|
||||||||||||||||
Cash dividends declared ($
|
- | ( |
) | ( |
) | |||||||||||||||||||
Repurchase of common stock
|
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Balance as of September 30, 2022
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
Nine Months Ended
September 30,
|
||||||||
(Dollars in thousands)
|
2023
|
2022
|
||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
|
$
|
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Provision for credit losses
|
|
|
||||||
Depreciation and amortization
|
|
|
||||||
Net amortization of securities premiums and discounts
|
|
|
||||||
Increase in cash surrender value of BOLI
|
(
|
)
|
(
|
)
|
||||
Gain on BOLI death benefit
|
( |
) | ||||||
(Increase)/decrease in deferred income taxes, net
|
(
|
)
|
|
|||||
Loss on sale of securities available-for-sale
|
|
|
||||||
Net changes in:
|
||||||||
Other assets
|
|
(
|
)
|
|||||
Other liabilities
|
|
|
||||||
Net cash provided by operating activities
|
|
|
||||||
Cash flows from investing activities:
|
||||||||
Net change in loans and leases held-for-investment
|
(
|
)
|
(
|
)
|
||||
Purchase of available-for-sale securities
|
(
|
)
|
(
|
)
|
||||
Purchase of held-to-maturity securities
|
(
|
)
|
(
|
)
|
||||
Proceeds from sales, maturities, calls and pay downs of available-for-sale securities
|
|
|
||||||
Proceeds from maturities, calls and pay downs of held-to-maturity securities
|
|
|
||||||
Purchase of premises and equipment
|
(
|
)
|
(
|
)
|
||||
Purchase of other investments
|
(
|
)
|
(
|
)
|
||||
Proceeds from bank-owned life insurance | ||||||||
Proceeds from sale of assets
|
|
|
||||||
Net cash provided by (used in) investing activities
|
|
(
|
)
|
|||||
Cash flows from financing activities:
|
||||||||
Net (decrease) increase in deposits
|
(
|
)
|
|
|||||
Cash dividends paid |
( |
) | ( |
) | ||||
Net cash used in share repurchase of common stock
|
(
|
)
|
(
|
)
|
||||
Net
cash (used in) provided by financing activities
|
(
|
)
|
|
|||||
Net change in cash and cash equivalents
|
|
|
||||||
Cash and cash equivalents, beginning of period
|
|
|
||||||
Cash and cash equivalents, end of period
|
$
|
|
$
|
|
||||
Supplemental disclosures of cash flow information:
|
||||||||
Cash paid for interest
|
$
|
|
$
|
|
||||
Income taxes paid |
$ | $ | ||||||
Supplemental disclosures of non-cash transactions:
|
||||||||
Net change in unrealized gain/(losses) on securities available-for-sale | $ | $ | ( |
) |
Available-for-Sale Securities
|
|
Gross Unrealized | |
|||||||||||||
(Dollars in thousands)
|
Amortized
Cost
|
Gains
|
Losses
|
Fair Value
|
||||||||||||
As of September 30, 2023 | ||||||||||||||||
U.S. Government-sponsored securities
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
Mortgage-backed securities (1)
|
|
|
|
|
||||||||||||
Collateralized mortgage obligations (1)
|
||||||||||||||||
Corporate securities
|
|
|
|
|
||||||||||||
Other
|
|
|
|
|
||||||||||||
Total available-for-sale securities
|
$
|
|
$
|
|
$
|
|
$
|
|
Available-for-Sale Securities |
|
Gross Unrealized
|
|
|||||||||||||
(Dollars in thousands)
|
Amortized
Cost
|
Gains
|
Losses
|
Fair Value
|
||||||||||||
As of December 31, 2022
|